I assessed an in vivo experiment to evaluate the blocking of PD-L1 in N. gonorrhea mice infection model. I observed a small positive impact of control IgG in mice bacterial burden. It is not good as anti-PD-L1 antibodies, but better than PBS control. I am trying to find some explanation in the literature. Unfortunately, I did not find a reason.